This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Douglas Joseph Zeckner: Innovator in Pseudomycin Natural Products
Introduction
Douglas Joseph Zeckner is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of natural products, particularly in the development of pseudomycin compounds. With a total of 2 patents to his name, Zeckner's work has implications for antifungal treatments.
Latest Patents
Zeckner's latest patents focus on pseudomycin natural products, specifically pseudomycins A′ and B′. These inventions detail methods for creating these pseudomycins and their antifungal applications. Advanced techniques such as NMR and mass spectrometry have been employed to determine the chemical formulas for pseudomycin A′ and B′, showcasing the innovative nature of his research.
Career Highlights
Zeckner is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to explore and develop new therapeutic options, particularly in the realm of antifungal agents.
Collaborations
Throughout his career, Zeckner has collaborated with talented individuals such as Palaniappan Kulanthaivel and Matthew David Belvo. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Douglas Joseph Zeckner's contributions to the field of pseudomycin natural products highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new antifungal treatments, making a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile